October 25, 2026

Clinical Oncology Education

The Evolution of Adjuvant Imatinib in Gastrointestinal Stromal Tumors: A Clinical State-of-the-Art Review the-evolution-of-adjuvant-imatinib-in-gastrointestinal-stromal-tumors-a-clinical-state-of-the-art-review

The Evolution of Adjuvant Imatinib in Gastrointestinal Stromal Tumors: A Clinical State-of-the-Art Review

Iffa Jayyana October 15, 2026
Main Facts: The Paradigm Shift in GIST Management Gastrointestinal stromal tumors (GISTs), though relatively rare, represent the...
Read More Read more about The Evolution of Adjuvant Imatinib in Gastrointestinal Stromal Tumors: A Clinical State-of-the-Art Review
Redefining the Standard of Care: The Evolution of Adjuvant Imatinib in Gastrointestinal Stromal Tumors (GIST) redefining-the-standard-of-care-the-evolution-of-adjuvant-imatinib-in-gastrointestinal-stromal-tumors-gist

Redefining the Standard of Care: The Evolution of Adjuvant Imatinib in Gastrointestinal Stromal Tumors (GIST)

Neng Nana October 14, 2026
Main Facts: The Paradigm Shift in Oncology Gastrointestinal stromal tumors (GIST), while rare, represent the most common...
Read More Read more about Redefining the Standard of Care: The Evolution of Adjuvant Imatinib in Gastrointestinal Stromal Tumors (GIST)
Redefining First-Line Care: Insights from the CheckMate 9DW Trial in Unresectable Hepatocellular Carcinoma redefining-first-line-care-insights-from-the-checkmate-9dw-trial-in-unresectable-hepatocellular-carcinoma

Redefining First-Line Care: Insights from the CheckMate 9DW Trial in Unresectable Hepatocellular Carcinoma

Nana October 13, 2026
The landscape of oncology is perpetually shifting, particularly within the challenging domain of advanced hepatocellular carcinoma (HCC)....
Read More Read more about Redefining First-Line Care: Insights from the CheckMate 9DW Trial in Unresectable Hepatocellular Carcinoma
Advancing the Frontier: An In-Depth Analysis of the CheckMate 9DW Trial in First-Line Hepatocellular Carcinoma advancing-the-frontier-an-in-depth-analysis-of-the-checkmate-9dw-trial-in-first-line-hepatocellular-carcinoma

Advancing the Frontier: An In-Depth Analysis of the CheckMate 9DW Trial in First-Line Hepatocellular Carcinoma

Ali Ikhwan October 13, 2026
The landscape of oncology is perpetually shifting, yet few areas have seen as rapid an evolution as...
Read More Read more about Advancing the Frontier: An In-Depth Analysis of the CheckMate 9DW Trial in First-Line Hepatocellular Carcinoma
Shaping the Future of Precision Oncology: OncoImmunology Launches Major Initiative on Adoptive Cell Therapies shaping-the-future-of-precision-oncology-oncoimmunology-launches-major-initiative-on-adoptive-cell-therapies

Shaping the Future of Precision Oncology: OncoImmunology Launches Major Initiative on Adoptive Cell Therapies

Nana Wu October 13, 2026
The landscape of cancer treatment is currently undergoing a paradigm shift, moving away from broad-spectrum chemotherapies toward...
Read More Read more about Shaping the Future of Precision Oncology: OncoImmunology Launches Major Initiative on Adoptive Cell Therapies

You may have missed

unraveling-the-colorectal-cancer-paradox-msk-researchers-discover-dual-roles-of-immune-cells-paving-way-for-new-therapies

Unraveling the Colorectal Cancer Paradox: MSK Researchers Discover Dual Roles of Immune Cells, Paving Way for New Therapies

Azzam Bilal Chamdy October 25, 2026
new-evidence-shows-depression-linked-to-circadian-rhythm

New evidence shows depression linked to circadian rhythm

Nana Muazin October 25, 2026
a-storm-of-resilience-brenjas-journey-through-triple-negative-breast-cancer

A Storm of Resilience: Brenja’s Journey Through Triple-Negative Breast Cancer

Azzam Bilal Chamdy October 25, 2026
bridging-the-gap-metavivors-2026-legislative-strategy-and-the-push-for-metastatic-breast-cancer-research-reform

Bridging the Gap: METAvivor’s 2026 Legislative Strategy and the Push for Metastatic Breast Cancer Research Reform

Dwi Wanna October 25, 2026